1,000 patients join study to unlock HER2+ breast cancer secrets

NCT ID NCT06603597

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 28 times

Summary

This study follows 1,000 people with HER2-positive breast cancer to see how patient and tumor features affect survival and treatment response. Researchers will track 5-year survival rates and how often tumors disappear completely after pre-surgery therapy. The goal is to gather knowledge, not test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HER2 + BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • KUCC - Briarcliff

    ACTIVE_NOT_RECRUITING

    Westwood, Kansas, 66205, United States

  • KUCC - Indian Creek

    ACTIVE_NOT_RECRUITING

    Overland Park, Kansas, 66211, United States

  • KUCC - Lee's Summit

    ACTIVE_NOT_RECRUITING

    Lee's Summit, Missouri, 64064, United States

  • KUCC - Olathe

    ACTIVE_NOT_RECRUITING

    Westwood, Kansas, 66205, United States

  • KUCC - Overland Park

    ACTIVE_NOT_RECRUITING

    Overland Park, Kansas, 66215, United States

  • The University of Kansas Cancer Center

    RECRUITING

    Westwood, Kansas, 66205, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.